Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $19,888 - $22,760
-100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $18,529 - $20,889
100 New
100 $21,000
Q4 2017

Feb 05, 2018

SELL
$168.79 - $188.59 $27,850 - $31,117
-165 Closed
0 $0
Q3 2017

Oct 30, 2017

SELL
$167.29 - $191.0 $12,044 - $13,752
-72 Reduced 30.38%
165 $31,000
Q2 2017

Aug 10, 2017

BUY
N/A
237
237 $41,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.